Furthermore, our experimental validation confirmed the high expression of SLC35A3 in CRC tissue, which was positively correlated with the infiltration of helper T cells, suggesting its favorable impact on anti-tumor immune response in CRC patients. This evidence concerns the gene SLC35A3 and neoplasm.